Identification of Probable Drug-Drug and Drug-Food Interactions in Hospitalized Patients With Chronic Renal Disease
Abstract
Chronic renal disease is a substantial health challenge in numerous countries worldwide, including Indonesia. Chronic renal disease patients frequently experience comorbidities and require multiple medications (polypharmacy). In patients receiving polypharmacy, it is necessary to monitor the occurrence of drug interactions. The current study analyzed the most probable of drug-drug interactions based on severity and management. Furthermore, to analyzed the most probable drug-food interactions based on severity and management in patients hospitalized with chronic renal disease. From September to October 2023, a cross-sectional study was carried out using retrospective data gathering. The population that attains the study criteria is referred to as the present research sample. The sampling methodology utilizes the saturated sample method. The tools utilized encompassed the Lexicomp® drug interaction checking application. The severity and management categories for probable drug-drug interactions and drug-food interactions are defined within the Lexicomp® application. The study analyzed medical data from 51 patients in total. The results of the current study showed that there were probable drug-drug interactions in 68.62% and drug-food interactions in 47.06% of patients hospitalized with chronic kidney disease. Based on severity, the most probable drug-drug interaction and drug-food interaction is in the moderate category. Based on the management, the most probable drug-drug interaction needs to be monitored, and the most probable drug-food interaction needs to be avoided concurrent administration with food. In patients with chronic renal disease, it is crucial to minimize and handle probable drug-drug and drug-food interactions.
Keywords
Full Text:
PDFReferences
Papotti, B., Marchi, C., Adorni, M. P. & Potì, F. Drug-drug interactions in polypharmacy patients: The impact of renal impairment. Current Research in Pharmacology and Drug Discovery 2, 100020 (2021).
ISSN:2527-7322 | e-ISSN: 2614-0020
kidney disease: an update 2022. Kidney
Int Suppl (2011) 12, 7 (2022).
WHO. Mortality and global health
estimates. World Health Organization https://www.who.int/data/gho/data/ themes/mortality-and-global-health- estimates (2019).
Hustrini, N. M. Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities. Acta Med Indones 55, 1 (2023).
Hustrini, N. M. et al. The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta. Ann Glob Health 89, 36–37 (2023).
Ministry of Health Indonesia. Health Survey Indonesia. (2023).
Santosa, C., Setyopuspito Pramitaningastuti, A., Setiawan, B., Ilmu Kesehatan, F. & Pelita Harapan, U. Overview of Polypharmacy and Drug Interactions in Chronic Kidney Disease Patients at Siloam Hospitals Lippo Village. Media Farmasi Indonesia 19, (2024).
Saibi, Y. et al. Drug Interaction Potency on Type 2 Diabetes Mellitus Patient in Hospital X in South Tangerang. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) 8, 100–104 (2018).
Bahana, I., Reyaan, M., Kuning, C. & Adnyana, K. Studi Potensi Interaksi Obat pada Resep Polifarmasi di Dua Apotek Kota Bandung. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) 11, 145–152 (2021).
Furdiyanti, N. H., Luhurningtyas, F. P., Sari, R. & Yulianti, Y. Evaluation of Oral Antidiabetic Dosing and Drug Interactions in Type 2 Diabetic Patients. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) 7, 191–196 (2018).
Kovesdy, C. P. Epidemiology of chronic
Saraswati, M. D. et al. Potential Drug–Drug Interactions in Ambulatory Patients with Hypertension: a Retrospective Study. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia 9, 69–74 (2022).
Perwirani, R. & Puspita Sari, I. Perancangan Clinical Decision Support System (CDSS) untuk Drug Drug Interaction (DDI) pada e-Prescription. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) 12, 198–207 (2023).
Herliany, Y. S. & Wahyuningsih, S. R. The Profile of Antihypertensive Drug Prescriptions and Interactions at Pindad General Hospital. Pharmacology and Clinical Pharmacy Research 5, 1–6 (2020).
Debus, J. L. et al. Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis. Ther Adv Chronic Dis 13, (2022).
Gougis, P. et al. Cytochrome P-450- mediated herb and food-drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study. ESMO Open 7, (2022).
Sari, O. M., Maulana, A. & Putra, P. Severity and Risk Rating of Drug-Drug Interaction Potency in Chronic Kidney Disease in Public Health Hospital. Journal of Pharmaceutical Care 78–87 (2024).
Khusfiani, T., Soetikno, V., Hustrini, N. M. & Nafrialdi, N. Evaluation of Potential Drug-Drug Interactions and Association with Adverse Drug Reactions in Predialysis Chronic Kidney Disease Patients at Indonesian National Referral Hospital. Acta Med Indones 55, 277 (2023).
Handayani, N., Faisal, M. & Rusli, R. Kajian Interaksi Obat pada Pasien Gagal Ginjal Rawat Inap di RSUD Panglima Sebaya Tanah Grogot. Jurnal Sains dan
ISSN:2527-7322 | e-ISSN: 2614-0020
Kesehatan 5, 500–506 (2023).
Probosiwi, N., Laili, N. F., Ilmi, T. &
Sisiwidiasari, A. Analisis Potensi Interaksi Obat Pada Pasien Gagal Ginjal Kronis Dengan Penyakit Penyerta Di RS X Kota Kediri : Analysis Of Potential Drug Interaction In Chronic Kidney Failure Patients With Comorbidities at X Hospital Kediri City. Jurnal Inovasi Farmasi Indonesia (JAFI) 5, 60–72 (2023).
Maria, N., Susilo, F. V. & Simarmata, M. Drug Selection, Dosage Adjustment, and Potential Interaction of Antihypertensive and Antidiabetic for Chronic Kidney Disease with Hemodialysis. Jurnal Ilmu Kefarmasian Indonesia 21, 254–265 (2023).
Primadhini, T. A., Almasdy, D. & A, A. Analisis Potensi Interaksi Obat Pada Pasien Gagal Ginjal Kronik (GGK) Stadium Akhir Di Rumah Sakit Aulia Pekanbaru. Jurnal Kesehatan Medika Saintika 14, 492–507 (2023).
Priatna, M., Pebiansyah, A. & Puspitasari, R. Profil Penggunaan Obat Dan Manajemen Risiko Pada Pasien Gagal Ginjal Kronik Dengan Hipertensi Di RSUD X. Prosiding Seminar Nasional Diseminasi Penelitian Volume 3 3, 2964–6154 (2023).
Marcath, L. A. et al. Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics. J Oncol Pract 14, e368–e374 (2018).
Lexicomp. Lexicomp Drug Interaction Checker. Lexicomp https://www. wolterskluwer.com/en/solutions/ lexicomp/lexicomp (2024).
Sari, O. M., Putra, A. M. P., Azizah, P. N. & Sofia, S. Therapy Profile and Drug Use Analysis of Chronic Kidney Disease Patients Hospitalized at Dr. H. M. Ansari Saleh Hospital: Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) 9, 233–246 (2023).
Sari, O. M., Maulana, A. & Putra, P. Severity and Risk Rating of Drug-Drug Interaction Potency in Chronic Kidney Disease in Public Health Hospital. Journal of Pharmaceutical Care (2024) doi:10.18502/JPC.V12I2.16185.
Abdollahi, M., Eslami, S., Taherzadeh, Z., Salehi, S. & Ebrahimi, M. Factors Associated with Potential Food-Drug Interaction in Hospitalized Patients: A Cross-Sectional Study in Northeast Iran. Evidence Based Care 8, 27–34 (2018).
Joany, S. et al. Prevalence and predictors of potential drug-food interactions among the elderly using prescription drugs. J Chem Pharm Res 8, 29–60 (2016).
Koni, A. A. et al. A comprehensive evaluation of potentially significant drug- drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs. BMC Cancer 22, (2022).
dos Anjos, M. K., Oliveira, T. C. S. da S. de, Moreira, M. B., Conceição Stipp, M. A. & Paes, G. O. Potential drug-food interactions in patients hospitalized in the Cardiology Unit. Revista de Nutrição 32, e180147 (2019).
Köse, I., Gençyürek, G., Altınbaş, Z., Beytiye, A. & Elmas, Ö. Analysis of drug- food interactions in inpatient treatment: A university hospital case. Med Res Arch 9, (2021).
Swarnakari, K. M. et al. The Effects of Proton Pump Inhibitors in Acid Hypersecretion-Induced Vitamin B12 Deficiency: A Systematic Review (2022). Cureus 14, (2022).
Alifiar, I. et al. Gambaran Potensi Interaksi Obat dengan Makanan pada Pasien Hepar yang Dirawat di Sebuah Rumah Sakit di Kota Tasikmalaya. Jurnal Surya Medika (JSM) 2, 47–52 (2016).
Baraka, M. A. et al. Awareness of statin– food interactions using grapefruit as an example: a cross-sectional study in Eastern Province of Saudi Arabia. Journal of
ISSN:2527-7322 | e-ISSN: 2614-0020
Pharmaceutical Health Services Research 12, 545–551 (2021).
DOI: https://doi.org/10.15416/pcpr.v9i2.56525
Refbacks
- There are currently no refbacks.
